Brigham and Women's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).
Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.
Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
937 total, page 14 of 19
Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia
NCT02419547
Flexibility and Strength Training in Asthma
NCT02370004
Tranexamic Acid and Thromboelastography During Cesarean Delivery
NCT02026297
Influence of Lumbar Ultrasound on Resident Learning Curve for Lateral Labor Epidural Placement
NCT02826668
Combined Medication for Improved Analgesia in Superficial Pain
NCT02194088
APOL1 Gene Variants in African American Kidney Transplant Recipients
NCT01442402
Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism
NCT02171273
Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants
NCT01853111
High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
NCT02064738
Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection
NCT02084706
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
NCT02015806
Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients
NCT02879357
Salt and TH-17 in Healthy Human Subjects
NCT02261688
The Study of Physical Activity Rewards After Knee Surgery
NCT01970631
Personalized Risk Estimator for Rheumatoid Arthritis Family Study
NCT02046005
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
NCT02008591
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
NCT03326206
Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.
NCT01928797
Study of the Physical Activity in Anesthesiologists
NCT01989494
Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?
NCT02192606
Synchronization to Improve Non-Adherence to Cardiovascular Medications
NCT01963156
Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation
NCT01895127
Multi-scale Modeling of Sleep Behaviors in Social Networks
NCT02846077
Evaluation of Yoga for Substance Use Risk Factors in a School Setting
NCT01821950
The Health Log: A Randomized Clinical Trial
NCT01913080
Hypoglycemia and Autonomic Nervous System Function-B
NCT03429946
Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety
NCT02134847
Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease
NCT01901224
A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
NCT01748695
Walnut Consumption, Endothelial Function, and Biomarkers
NCT01884363
Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions
NCT02130570
Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
NCT01855360
Preoperative Cognitive Screening of Elderly Surgical Patients
NCT01826825
Effects of Light on Melatonin and Contractions in Pregnant Women
NCT01863446
Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions
NCT01847209
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
NCT01754259
Cardiovascular Inflammation Reduction Trial
NCT01594333
Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography
NCT01683825
Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
NCT02549495
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
NCT01691612
The Effects of Trazodone on Sleep Apnea Severity
NCT01817907
Promoting Respect and Ongoing Safety Through Patient-centeredness, Engagement, Communication and Technology
NCT02258594
Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis
NCT01689441
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
NCT01468675
Endoscopic Suturing for Primary Obesity Treatment
NCT01662024
Borage and Echium Seed Oils for Asthma
NCT01560988
Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury
NCT02200120
Beliefs and Practice Intentions of Future Ob/Gyn Residents Regarding Reproductive Healthcare
NCT01763073
Riluzole Augmentation Pilot in Depression (RAPID) Trial
NCT01703039
Functional Applications of Hyperpolarized 129Xe MRI
NCT01697332
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 90 |
| Phase 2 | 107 |
| Phase 3 | 47 |
| Phase 4 | 77 |
Therapeutic Areas
What is open in the Brigham and Women's Hospital pipeline
145 recruiting of 937 indexed (15% open); 608 completed (65%).
Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brigham and Women's Hospital: open-pipeline peers nationwide
Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 937 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of Minnesota · 966 trials · 19% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Incyte Corporation · 15% recruiting · 239 trials
- Northwestern University · 15% recruiting · 1,209 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Brigham and Women's Hospital page
937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.
- 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.